URANIUM ROYALTY CORP (UROY) Stock Fundamental Analysis
USA - NASDAQ:UROY - CA91702V1013 - Common Stock
4.86 USD
-0.04 (-0.82%)
4.77 USD
-0.09 (-1.85%)
We assign a fundamental rating of 3 out of 10 to UROY. UROY was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. UROY has a great financial health rating, but its profitability evaluates not so good. UROY has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year UROY has reported negative net income.
UROY had a positive operating cash flow in the past year.
In the past 5 years UROY reported 4 times negative net income.
In the past 5 years UROY always reported negative operating cash flow.
1.2 Ratios
UROY has a Return On Assets of -0.66%. This is in the lower half of the industry: UROY underperforms 70.48% of its industry peers.
UROY has a Return On Equity of -0.66%. This is in the lower half of the industry: UROY underperforms 67.62% of its industry peers.
UROY has a Return On Invested Capital of 0.12%. This is in the lower half of the industry: UROY underperforms 74.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | -0.66% | ||
| ROIC | 0.12% |
ROA(3y)-0.51%
ROA(5y)-1.15%
ROE(3y)-0.57%
ROE(5y)-1.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
UROY's Operating Margin of 0.94% is on the low side compared to the rest of the industry. UROY is outperformed by 73.33% of its industry peers.
Looking at the Gross Margin, with a value of 18.11%, UROY is doing worse than 66.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.94% | ||
| PM (TTM) | N/A | ||
| GM | 18.11% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
UROY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for UROY has been increased compared to 1 year ago.
UROY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UROY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 413.47 indicates that UROY is not in any danger for bankruptcy at the moment.
The Altman-Z score of UROY (413.47) is better than 99.52% of its industry peers.
The Debt to FCF ratio of UROY is 0.01, which is an excellent value as it means it would take UROY, only 0.01 years of fcf income to pay off all of its debts.
UROY has a better Debt to FCF ratio (0.01) than 92.86% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that UROY is not too dependend on debt financing.
UROY has a better Debt to Equity ratio (0.00) than 83.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 413.47 |
ROIC/WACC0.02
WACC7.92%
2.3 Liquidity
A Current Ratio of 201.73 indicates that UROY has no problem at all paying its short term obligations.
UROY has a better Current ratio (201.73) than 100.00% of its industry peers.
A Quick Ratio of 41.86 indicates that UROY has no problem at all paying its short term obligations.
UROY has a Quick ratio of 41.86. This is amongst the best in the industry. UROY outperforms 99.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 201.73 | ||
| Quick Ratio | 41.86 |
3. Growth
3.1 Past
The earnings per share for UROY have decreased strongly by -117.00% in the last year.
UROY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.29%.
EPS 1Y (TTM)-117%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%157%
Revenue 1Y (TTM)14.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
UROY is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -148.34% yearly.
The Revenue is expected to decrease by -37.41% on average over the next years. This is quite bad
EPS Next Y700.6%
EPS Next 2Y-246.58%
EPS Next 3Y-148.34%
EPS Next 5YN/A
Revenue Next Year174.39%
Revenue Next 2Y-75.5%
Revenue Next 3Y-37.41%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for UROY. In the last year negative earnings were reported.
Also next year UROY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UROY is valued a bit more expensive than 74.29% of the companies in the same industry.
UROY's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 62.69 | ||
| EV/EBITDA | 1319.51 |
4.3 Compensation for Growth
UROY's earnings are expected to decrease with -148.34% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-246.58%
EPS Next 3Y-148.34%
5. Dividend
5.1 Amount
UROY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.86
-0.04 (-0.82%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners28.31%
Inst Owner Change-0.27%
Ins Owners2.18%
Ins Owner ChangeN/A
Market Cap649.49M
Revenue(TTM)48.81M
Net Income(TTM)-1971000
Analysts75
Price Target3.82 (-21.4%)
Short Float %7.6%
Short Ratio2.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.73%
PT rev (3m)11.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)219.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)30.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 18.67 | ||
| P/FCF | 62.69 | ||
| P/OCF | 41.84 | ||
| P/B | 3.07 | ||
| P/tB | 3.07 | ||
| EV/EBITDA | 1319.51 |
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.08
FCFY1.6%
OCF(TTM)0.12
OCFY2.39%
SpS0.26
BVpS1.58
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | -0.66% | ||
| ROCE | 0.16% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.15% | ||
| OM | 0.94% | ||
| PM (TTM) | N/A | ||
| GM | 18.11% | ||
| FCFM | 29.77% |
ROA(3y)-0.51%
ROA(5y)-1.15%
ROE(3y)-0.57%
ROE(5y)-1.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 4472.22% | ||
| Cap/Sales | 14.84% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 3495.51% | ||
| Profit Quality | N/A | ||
| Current Ratio | 201.73 | ||
| Quick Ratio | 41.86 | ||
| Altman-Z | 413.47 |
F-Score5
WACC7.92%
ROIC/WACC0.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%157%
EPS Next Y700.6%
EPS Next 2Y-246.58%
EPS Next 3Y-148.34%
EPS Next 5YN/A
Revenue 1Y (TTM)14.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year174.39%
Revenue Next 2Y-75.5%
Revenue Next 3Y-37.41%
Revenue Next 5YN/A
EBIT growth 1Y-92.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year142.68%
EBIT Next 3Y3.56%
EBIT Next 5YN/A
FCF growth 1Y345.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y468.48%
OCF growth 3YN/A
OCF growth 5YN/A
URANIUM ROYALTY CORP / UROY FAQ
What is the fundamental rating for UROY stock?
ChartMill assigns a fundamental rating of 3 / 10 to UROY.
What is the valuation status of URANIUM ROYALTY CORP (UROY) stock?
ChartMill assigns a valuation rating of 1 / 10 to URANIUM ROYALTY CORP (UROY). This can be considered as Overvalued.
How profitable is URANIUM ROYALTY CORP (UROY) stock?
URANIUM ROYALTY CORP (UROY) has a profitability rating of 0 / 10.
How financially healthy is URANIUM ROYALTY CORP?
The financial health rating of URANIUM ROYALTY CORP (UROY) is 8 / 10.
Can you provide the expected EPS growth for UROY stock?
The Earnings per Share (EPS) of URANIUM ROYALTY CORP (UROY) is expected to grow by 700.6% in the next year.